Today, the CFO of Atrion Corp (ATRI), Jeffery Strickland, sold shares of ATRI for $1.54M.
Following Jeffery Strickland’s last ATRI Sell transaction on December 19, 2016, the stock climbed by 294.3%.
See today’s analyst top recommended stocks >>
Based on Atrion Corp’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $39.27 million and quarterly net profit of $9.22 million. In comparison, last year the company earned revenue of $37.9 million and had a net profit of $7.97 million. ATRI’s market cap is $1.45B and the company has a P/E ratio of 41.43. Currently, Atrion Corp has an average volume of 5,675.
Jeffery Strickland’s trades have generated a -19.9% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Atrion Corp. engages in the manufacture and development of products for medical applications. Its products include cardiac surgery vacuum relief valves, Retract-O-Tape silicone vessel loops, for retraction and occluding vessels in minimally invasive surgical procedures, and CleanCut rotating aortic punch.
